Copyright: Immunotech Applied Science Limited   京ICP备19008112号-1    

Company News
Industry News
SPECIAL TOPIC OF INNOVATIVE DRUGS: CAR-T CELL THERAPY | OVERVIEW OF MARKET AND PRODUCT DEVELOPMENT, R&D TREND AND COMMERCIALIZATION TREND
CELL AND GENE THERAPY WILL BE THE KEY DEVELOPMENT DIRECTION OF BEIJING'S PHARMACEUTICAL AND HEALTH INDUSTRY
DISCUSSION ON THE KEY POINTS OF CMC RESEARCH IN VARIOUS STAGES OF INNOVATIVE DRUGS
SUMMARY | 46 GLOBALLY AVAILABLE GENE THERAPY DRUGS
THE DEVELOPMENT MOMENTUM OF CELL THERAPY IN CHINA IS STRONG, WITH 14 APPROVED CLINICAL PRODUCTS AND 24 NEWLY ACCEPTED PRODUCTS IN THE FIRST QUARTER
THE INDEPENDENT RESEARCH AND DEVELOPMENT INNOVATION AND INDUSTRIALIZATION OF BIOTECHNOLOGY AND BIG HEALTH INDUSTRIES IN BEIJING ECONOMIC-TECHNOLOGICAL DEVELOPMENT AREA "DOUBLE ACCELERATION"
WEEKLY NEWS OVERVIEW OF CELL GENE THERAPY INDUSTRY (~2023.4.17)
WEEKLY NEWS OVERVIEW OF CELL GENE THERAPY INDUSTRY (~2023.04.10)
WEEKLY NEWS OVERVIEW OF CELL GENE THERAPY INDUSTRY (~2023.04.03)
WEEKLY HIGHLIGHTS OF THE CELL GENE THERAPY INDUSTRY (~2023.3.27)
Page up
1
2
...
4